Endothelial Targeting of High-Affinity Multivalent Polymer Nanocarriers Directed to Intercellular Adhesion Molecule 1

Silvia Muro, Thomas D. Dziubla, Weining Qiu, +4

Journal of Pharmacology and Experimental Therapeutics

The Noxa/Mcl-1 Axis Regulates Susceptibility to Apoptosis under Glucose Limitation in Dividing T Cells

Nuno L. Alves, Ingrid A. M. Derks, Erik Berk, +3

Immunity

Cell RegulationTumor MicroenvironmentCell DivisionGlucose LimitationApoptosis +9

IL-18–Primed Helper NK Cells Collaborate with Dendritic Cells to Promote Recruitment of Effector CD8+ T Cells to the Tumor Microenvironment

Jeffrey L. Wong, Erik Berk, Robert P. Edwards, +1

Cancer Research

NF-κB Hyperactivation in Tumor Tissues Allows Tumor-Selective Reprogramming of the Chemokine Microenvironment to Enhance the Recruitment of Cytolytic T Effector Cells

Ravikumar Muthuswamy, Erik Berk, Beth Fallert Junecko, +7

Cancer Research

Nf-κb HyperactivationImmunologyImmunoeditingImmunotherapeuticsT Cells +16

Effect of flow on endothelial endocytosis of nanocarriers targeted to ICAM-1

Tridib Kumar Bhowmick, Erik Berk, Xiumin Cui, +2

Journal of Controlled Release

NanomedicineAngiogenesisEngineeringEndothelial EndocytosisImmunology +9

Independent Regulation of Chemokine Responsiveness and Cytolytic Function versus CD8+ T Cell Expansion by Dendritic Cells

Payal Watchmaker, Erik Berk, Ravikumar Muthuswamy, +4

The Journal of Immunology

T-regulatory CellImmunologyImmunologic MechanismImmunotherapyIndependent Regulation +17

Association of Depressed Anti-HER2 T-Helper Type 1 Response With Recurrence in Patients With Completely Treated HER2-Positive Breast Cancer

Jashodeep Datta, Megan Fracol, Matthew T. McMillan, +6

JAMA Oncology

Progressive loss of anti-HER2 CD4⁺ T-helper type 1 response in breast tumorigenesis and the potential for immune restoration

Jashodeep Datta, Cinthia Rosemblit, Erik Berk, +14

OncoImmunology

Anti-HER2 CD4+ T-helper type 1 response is a novel immune correlate to pathologic response following neoadjuvant therapy in HER2-positive breast cancer

Jashodeep Datta, Erik Berk, Shuwen Xu, +10

Breast Cancer Research

Memory CD8+ T Cells Protect Dendritic Cells from CTL Killing

Payal Watchmaker, Julie Urban, Erik Berk, +5

The Journal of Immunology